REBOOT Trademark

Trademark Overview


On Tuesday, August 30, 2011, a trademark application was filed for REBOOT with the United States Patent and Trademark Office. The USPTO has given the REBOOT trademark a serial number of 85410666. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 10, 2013. This trademark is owned by Accentia Biopharmaceuticals, Inc.. The REBOOT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing a website featuring technology that enables physicians, pharmacists, and patients to search databases for patients suffering from immune disorders and malignancies who are using or will benefit from oxazaphosphorine pharmaceuticals, to maintain a medical registry containing information regarding patients suffering from immune disorders and malignancies who are using or will benefit from oxazaphosphorine pharmaceuticals, to engage in interactive record keeping relating to patients suffering from immune disorders and malignancies who are using or will benefit from oxazaphosphorine pharmaceuticals, to distribute information on the safe and effective use of oxazaphosphorine pharmaceuticals, and to set reminders and send notices to physicians and pharmacists for the purpose of minimizing drug interactions
reboot

General Information


Serial Number85410666
Word MarkREBOOT
Filing DateTuesday, August 30, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 10, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 11, 2012

Trademark Statements


Goods and ServicesProviding a website featuring technology that enables physicians, pharmacists, and patients to search databases for patients suffering from immune disorders and malignancies who are using or will benefit from oxazaphosphorine pharmaceuticals, to maintain a medical registry containing information regarding patients suffering from immune disorders and malignancies who are using or will benefit from oxazaphosphorine pharmaceuticals, to engage in interactive record keeping relating to patients suffering from immune disorders and malignancies who are using or will benefit from oxazaphosphorine pharmaceuticals, to distribute information on the safe and effective use of oxazaphosphorine pharmaceuticals, and to set reminders and send notices to physicians and pharmacists for the purpose of minimizing drug interactions

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 2, 2012
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAccentia Biopharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTampa, FL 33606

Party NameAccentia Biopharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTampa, FL 33606

Trademark Events


Event DateEvent Description
Monday, June 10, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 10, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 6, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 11, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 11, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 22, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 3, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 1, 2012ASSIGNED TO LIE
Wednesday, July 18, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 2, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 2, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 2, 2012TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sunday, June 24, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, June 24, 2012FINAL REFUSAL E-MAILED
Sunday, June 24, 2012FINAL REFUSAL WRITTEN
Thursday, May 31, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 31, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 31, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 19, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 19, 2011NON-FINAL ACTION E-MAILED
Monday, December 19, 2011NON-FINAL ACTION WRITTEN
Saturday, December 17, 2011ASSIGNED TO EXAMINER
Saturday, September 3, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 2, 2011NEW APPLICATION ENTERED IN TRAM